Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biosceptre International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10659
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers. The company also develops diagnostics and a line of veterinary therapeutic products. It has operations in the UK, Australia, and the US. Biosceptre is headquartered in Cambridge, the UK.

Biosceptre International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
Partnerships 16
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd – Key Competitors 17
Biosceptre International Ltd – Key Employees 18
Biosceptre International Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd, Key Competitors 17
Biosceptre International Ltd, Key Employees 18
Biosceptre International Ltd, Subsidiaries 19

List of Figures
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務分析
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Crescendo Biologics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company s pipeline includes humabody programs targeting oncology. It specializes in the antibody discoveries and development that include CAT, …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Biowa Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biowa Inc (BioWa), a subsidiary of Kyowa Hakko Kirin Co Ltd (KHK), is a science and technology company that provides out licensing of therapeutic antibody technologies of KHK. The company also developes fucose free monoclonal antibodies that increase cellular cytotoxicity. Its technology inc …
  • TranSystems Corporation:企業の戦略・SWOT・財務情報
    TranSystems Corporation - Strategy, SWOT and Corporate Finance Report Summary TranSystems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tribune Media Company:企業の戦略・SWOT・財務情報
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Webjet Limited:企業の戦略・SWOT・財務情報
    Webjet Limited - Strategy, SWOT and Corporate Finance Report Summary Webjet Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Targa Resources Partners LP (NGLS PR A)-石油・ガス分野:企業M&A・提携分析
    Summary Targa Resources Partners LP (Targa Resources) is an independent midstream company. The company provides midstream natural gas and natural gas liquids (NGL) services. Targa Resources carries out the gathering, compressing, treating, processing and selling of natural gas, and storing, fraction …
  • Taiwan Power Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Taiwan Power Company Ltd (Taiwan Power) is an integrated state-owned electric utility that offers electricity generation, transmission and distribution services. The utility generates electricity through various fuel resources including thermal, coal, gas, cogeneration and renewable sources. …
  • Genesis Energy:企業の戦略・SWOT・財務情報
    Genesis Energy - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Tech Mahindra Limited:企業の戦略・SWOT・財務情報
    Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Tech Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Southern California Edison Co-エネルギー分野:企業M&A・提携分析
    Summary Southern California Edison Company (SCE), a subsidiary of Edison International, is an electric utility that generates, procures, sources, and supplies electricity. The company generates electricity from various sources including natural gas, hydro, nuclear, solar, and oil and gas. It sources …
  • Semiconductor Manufacturing International Corporation
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …
  • Allinky Biopharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …
  • Antibe Therapeutics Inc (ATE):医療機器:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆